Indiana University School of Medicine, Indianapolis, Indiana.
University of Michigan School of Medicine, Ann Arbor, Michigan.
Physiol Genomics. 2021 Jan 1;53(1):1-11. doi: 10.1152/physiolgenomics.00104.2020. Epub 2020 Nov 16.
Comprehensive and spatially mapped molecular atlases of organs at a cellular level are a critical resource to gain insights into pathogenic mechanisms and personalized therapies for diseases. The Kidney Precision Medicine Project (KPMP) is an endeavor to generate three-dimensional (3-D) molecular atlases of healthy and diseased kidney biopsies by using multiple state-of-the-art omics and imaging technologies across several institutions. Obtaining rigorous and reproducible results from disparate methods and at different sites to interrogate biomolecules at a single-cell level or in 3-D space is a significant challenge that can be a futile exercise if not well controlled. We describe a "follow the tissue" pipeline for generating a reliable and authentic single-cell/region 3-D molecular atlas of human adult kidney. Our approach emphasizes quality assurance, quality control, validation, and harmonization across different omics and imaging technologies from sample procurement, processing, storage, shipping to data generation, analysis, and sharing. We established benchmarks for quality control, rigor, reproducibility, and feasibility across multiple technologies through a pilot experiment using common source tissue that was processed and analyzed at different institutions and different technologies. A peer review system was established to critically review quality control measures and the reproducibility of data generated by each technology before their being approved to interrogate clinical biopsy specimens. The process established economizes the use of valuable biopsy tissue for multiomics and imaging analysis with stringent quality control to ensure rigor and reproducibility of results and serves as a model for precision medicine projects across laboratories, institutions and consortia.
全面且具有空间映射的器官分子图谱在细胞水平上是深入了解疾病发病机制和个体化治疗的关键资源。肾脏精准医学计划 (KPMP) 是一项通过在多个机构中使用多种最先进的组学和成像技术生成健康和患病肾脏活检的三维 (3-D) 分子图谱的努力。从不同的方法和不同的地点获取严格且可重复的结果,以在单细胞水平或 3-D 空间中检测生物分子,这是一个重大挑战,如果控制不当,可能会徒劳无功。我们描述了一种生成可靠和真实的人类成年肾脏单细胞/区域 3-D 分子图谱的“跟随组织”管道。我们的方法强调质量保证、质量控制、验证和不同组学和成像技术之间的协调,从样本获取、处理、存储、运输到数据生成、分析和共享。我们通过使用来自不同机构和技术的常见源组织进行处理和分析的试点实验,为质量控制、严格性、可重复性和多种技术的可行性建立了基准。建立了同行评审系统,在批准每种技术用于检测临床活检样本之前,对质量控制措施和数据可重复性进行严格审查。该流程通过严格的质量控制,在多组学和成像分析中节省了有价值的活检组织的使用,以确保结果的严格性和可重复性,并为跨实验室、机构和联盟的精准医学项目提供了模型。